NEW YORK (GenomeWeb News) – ShanghaiBio will offer Ingenuity Systems' solutions for downstream analysis and interpretation of genomics data as part of its laboratory services under a deal announced today between the firms.
ShanghaiBio will create a bundled solution with Ingenuity's applications, which combine analytics and biomedical content, supporting the complete workflow from study design to bioinformatic analysis, it said.
"Many organizations including pharmaceutical companies, biotech firms, and universities have growing programs for translational medicine research and are faced with analyzing and understanding complex data," ShanghaiBio CEO Jason Jin said in a statement. "With Ingenuity's solutions, we are helping our customers rapidly obtain a detailed assessment of their data so they can move to the next phase of their research."
Financial and other terms of the deal were not disclosed.
ShanghaiBio has offices in New York as well as Shanghai, and offers genomic services for translational medicine with a focus on biobanking, microarrays, next-generation sequencing, and biomarker assay development and companion diagnostics for personalized medicine, it said.